GABLOFEN 1 mL in 1 SYRINGE, GLASS: payments to doctors
Payments that named GABLOFEN 1 mL in 1 SYRINGE, GLASS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $38K
- Providers
- 178
- Transactions
- 332
- Average per transaction
- $114
The per-transaction average — $114 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 178 providers the average total is $213, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Piramal Critical Care | $37,935 | 100.0% |